Intercontinental Exchange to Dual-List on NYSE Texas-June 2024-www.financetom.com

Intercontinental Exchange to Dual-List on NYSE Texas

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Intercontinental Exchange to Dual-List on NYSE Texas

Jun 16, 2025 5:15 AM

07:57 AM EDT, 06/16/2025 (MT Newswires) -- Intercontinental Exchange ( ICE ) said Monday it will dual-list shares on the NYSE Texas, effective Tuesday.

The company said it will retain its primary listing on the New York Stock Exchange.

Previous page： Next Boeing CEO should understand past mistakes, airlines boss says Next page： OPEC+ agrees to extend voluntary output cuts into Q3'24, talks continue, sources say

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Next Boeing CEO should understand past mistakes, airlines boss says

Jun 2, 2024

DUBAI, June 2 (Reuters) - The next Boeing ( BA ) CEO should have an understanding of what led up to its current crisis and be prepared to look outside for examples of best industrial practices, the head of the International Air Transport Association said on Sunday. It is not for me to say who should be running Boeing (...

OPEC+ agrees to extend voluntary output cuts into Q3'24, talks continue, sources say

Jun 2, 2024

LONDON (Reuters) - OPEC+ has agrees to extend voluntary oil production cuts of 2.2 million barrels per day into the third quarter of 2024, two OPEC+ sources said on Sunday. Talks about cuts for the fourth quarter and 2025 continue, the sources said. (Reporting by OPEC Newsroom; Editing by Emelia Sithole-Matarise) ...

GSK blood cancer drug nearly halves risk of death in late-stage trial

Jun 2, 2024

June 2 (Reuters) - GSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late-stage study presented at a medical meeting on Sunday. In the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in...

Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes

Jun 2, 2024

June 2 (Reuters) - Treatment with Bristol Myers Squibb's ( BMY ) immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer had spread to lymph nodes had better outcomes than those who did not get the drugs before node removal procedures, according to data from a late-stage trial released on Sunday. The study of 423 patients with...